These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus. Isorce N; Testoni B; Locatelli M; Fresquet J; Rivoire M; Luangsay S; Zoulim F; Durantel D Antiviral Res; 2016 Jun; 130():36-45. PubMed ID: 26971407 [TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro. Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247 [TBL] [Abstract][Full Text] [Related]
26. The IL-1R/TLR signaling pathway is essential for efficient CD8 Ma Z; Liu J; Wu W; Zhang E; Zhang X; Li Q; Zelinskyy G; Buer J; Dittmer U; Kirschning CJ; Lu M Cell Mol Immunol; 2017 Dec; 14(12):997-1008. PubMed ID: 28757610 [TBL] [Abstract][Full Text] [Related]
27. Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies. Chen J; Yuan Z Virol Sin; 2014 Feb; 29(1):17-24. PubMed ID: 24452540 [TBL] [Abstract][Full Text] [Related]
28. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells. Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962 [TBL] [Abstract][Full Text] [Related]
29. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections. Zhang X; Kraft A; Broering R; Schlaak JF; Dittmer U; Lu M Expert Opin Drug Discov; 2012 Jul; 7(7):597-611. PubMed ID: 22607384 [TBL] [Abstract][Full Text] [Related]
30. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874 [TBL] [Abstract][Full Text] [Related]
31. Crosstalk between innate and adaptive immunity in hepatitis B virus infection. Wang L; Wang K; Zou ZQ World J Hepatol; 2015 Dec; 7(30):2980-91. PubMed ID: 26730277 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance. Lan P; Zhang C; Han Q; Zhang J; Tian Z Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417 [TBL] [Abstract][Full Text] [Related]
33. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO. Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism. van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316 [TBL] [Abstract][Full Text] [Related]
35. [Toll-like receptor dependent innate immune responses by primary mouse hepatocytes and its control of HBV replication]. Wu J; Chen MF; Xia YC; Guo Y; Lin Y; Sun C; Zhang CY; Chen Y; Liu SP; Hao YH; Lu MJ; Schlaak JF; Yang DL Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):838-42. PubMed ID: 22433306 [TBL] [Abstract][Full Text] [Related]
36. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line. Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184 [TBL] [Abstract][Full Text] [Related]
37. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri. Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the innate immune signalling pathways in hepatocyte cell lines. Preiss S; Thompson A; Chen X; Rodgers S; Markovska V; Desmond P; Visvanathan K; Li K; Locarnini S; Revill P J Viral Hepat; 2008 Dec; 15(12):888-900. PubMed ID: 18673429 [TBL] [Abstract][Full Text] [Related]
39. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy. Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531 [TBL] [Abstract][Full Text] [Related]
40. Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections. Li X; Liu X; Tian L; Chen Y Clin Rev Allergy Immunol; 2016 Feb; 50(1):41-54. PubMed ID: 25480494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]